These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 14668699)

  • 1. The relation of insulin resistance syndromes to risk of cardiovascular disease.
    Nesto RW
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S11-8. PubMed ID: 14668699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.
    Kendall DM; Harmel AP
    Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of macrovascular disease in type 2 diabetes. Role of insulin resistance.
    Stern M
    Diabetes Care; 1999 Apr; 22 Suppl 3():C2-5. PubMed ID: 10189555
    [No Abstract]   [Full Text] [Related]  

  • 4. From hyperglycemia to the risk of cardiovascular disease.
    Leiter LA
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
    Ahmed I; Goldstein BJ
    Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance.
    Tennyson GE
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S450-9. PubMed ID: 12408408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-resistance syndrome and cardiovascular complications of non-insulin-dependent diabetes mellitus.
    Fontbonne A
    Diabetes Metab; 1996 Oct; 22(5):305-13. PubMed ID: 8896991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in patients with polycystic ovary syndrome.
    Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
    Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of vascular disease in hypertension with special reference to diabetes.
    Yudkin JS
    Semin Vasc Med; 2002 May; 2(2):139-48. PubMed ID: 16222605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiologist's role in improving glucose control and global cardiovascular risk in patients with type 2 diabetes mellitus.
    Gotto AM
    Am J Cardiol; 2007 Feb; 99(4A):3B-5B. PubMed ID: 17307053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the thiazolidinediones in the practical management of patients with type 2 diabetes and cardiovascular risk factors.
    Edelman SV
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S29-37. PubMed ID: 14668701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycaemia and cardiovascular disease.
    Bartnik M; Norhammar A; Rydén L
    J Intern Med; 2007 Aug; 262(2):145-56. PubMed ID: 17645583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance--a common link between type 2 diabetes and cardiovascular disease.
    Lebovitz HE
    Diabetes Obes Metab; 2006 May; 8(3):237-49. PubMed ID: 16634983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D; Nyström T
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is insulin resistance atherogenic? A review of the evidence.
    Ferrannini E; Iozzo P
    Atheroscler Suppl; 2006 Aug; 7(4):5-10. PubMed ID: 16824807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of hyperglycemia and insulin with diabetic cardiovascular complications.
    Khamaisi M; Wainstein J; Hancu N; Milicevic Z; Raz I
    Isr Med Assoc J; 2003 Feb; 5(2):116-9. PubMed ID: 12674662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Obesity related complications in children and adolescents].
    Fichna P; Skowrońska B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):223-8. PubMed ID: 17020660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.